Abstract:Improper use of antimicrobials has resulted in the emergence of antimicrobial resistance (AMR), including multi-drug resistance (MDR) among bacteria. Recently, a sudden increase in Carbapenem-resistant Enterobacterales (CRE) has been observed. This presents a substantial challenge in the treatment of CRE-infected individuals. Bacterial plasmids include the genes for carbapenem resistance, which can also spread to other bacteria to make them resistant. The incidence of CRE is rising significantly despite the ef… Show more
“…Among the 53 CRE in our study, Klebsiella pneumoniae was the most predominant species, representing 69.8%, followed by E. coli (28.3%) and Klebsiella oxytoca (1.9%). Similarly, in Turkey, Baran and Aksu reported that the most common CRE species was Klebsiella pneumoniae (38.12 %), followed by E. coli (7.18 %) and Klebsiella oxytoca (0.55 %) 35 . On the contrary, a study in Nigeria reported that the most common CRE species were K. oxytoca 41%, then K. pneumoniae 32% and E. coli 27% 36 .…”
Background: Carbapenemase-producing Enterobacterales are increasingly spreading in healthcare facilities. Identifying the type of carbapenemase can help epidemiologic surveillance and proper selection of antimicrobials. Objective: This study assessed the sensitivity and specificity of carbapenem inactivation method (mCIM with eCIM) for identification of carbapenemase-production. Methodology: The study involved 150 isolates of Enterobacterales. Carbapenem-resistant isolates by Kirby Bauer method were further tested for carbapenemase production phenotypically by mCIM with eCIM, and genotypically by multiplex PCR using specific primers for bla KPC , bla OXA-48 , bla NDM-1 , bla VIM , and bla IMP. Results: Resistance to carbapenem was observed in 53/150 isolates. Phenotypically, 28/53 isolates produced metallo-β-lactamase, 16/53 produced serine carbapenemase, 5/53 isolates gave inconclusive results, and 4/53 were negative by mCIM with eCIM test. Genotypically, 30 isolates carried bla NDM-1 , and 41 isolates carried bla . Both genes co-existed in 18 Metallo-β-lactamase producers. The 9 isolates with negative or inconclusive results carried carbapenemase-encoding genes. For mCIM with eCIM test the sensitivity and specificity of detecting Metallo-β-lactamase production were higher (87% and 91%) than for serine carbapenemase detection (34% and 83%), respectively. Conclusion: It was concluded that the mCIM with eCIM test does not always lead to true conclusions about the existence and the type of carbapenemase produced by Enterobacterales.
“…Among the 53 CRE in our study, Klebsiella pneumoniae was the most predominant species, representing 69.8%, followed by E. coli (28.3%) and Klebsiella oxytoca (1.9%). Similarly, in Turkey, Baran and Aksu reported that the most common CRE species was Klebsiella pneumoniae (38.12 %), followed by E. coli (7.18 %) and Klebsiella oxytoca (0.55 %) 35 . On the contrary, a study in Nigeria reported that the most common CRE species were K. oxytoca 41%, then K. pneumoniae 32% and E. coli 27% 36 .…”
Background: Carbapenemase-producing Enterobacterales are increasingly spreading in healthcare facilities. Identifying the type of carbapenemase can help epidemiologic surveillance and proper selection of antimicrobials. Objective: This study assessed the sensitivity and specificity of carbapenem inactivation method (mCIM with eCIM) for identification of carbapenemase-production. Methodology: The study involved 150 isolates of Enterobacterales. Carbapenem-resistant isolates by Kirby Bauer method were further tested for carbapenemase production phenotypically by mCIM with eCIM, and genotypically by multiplex PCR using specific primers for bla KPC , bla OXA-48 , bla NDM-1 , bla VIM , and bla IMP. Results: Resistance to carbapenem was observed in 53/150 isolates. Phenotypically, 28/53 isolates produced metallo-β-lactamase, 16/53 produced serine carbapenemase, 5/53 isolates gave inconclusive results, and 4/53 were negative by mCIM with eCIM test. Genotypically, 30 isolates carried bla NDM-1 , and 41 isolates carried bla . Both genes co-existed in 18 Metallo-β-lactamase producers. The 9 isolates with negative or inconclusive results carried carbapenemase-encoding genes. For mCIM with eCIM test the sensitivity and specificity of detecting Metallo-β-lactamase production were higher (87% and 91%) than for serine carbapenemase detection (34% and 83%), respectively. Conclusion: It was concluded that the mCIM with eCIM test does not always lead to true conclusions about the existence and the type of carbapenemase produced by Enterobacterales.
“…This could be problematic when trying to detect chromosomal AMR genes. Nonetheless, the most prevalent BSI causative antimicrobial resistance strains (MRSA, Vancomycin-Resistant Enterococcus , Multidrug-Resistant Enterobacteriaceae , Extended-Spectrum β-Lactamase (ESBL) gram-negative species or Carbapenem-Resistant Enterobacterales [ 56 ]), generally have plasmid-mediated resistant mechanisms [ 71 – 75 ]. Because of the low coverage obtained in two of the genes present on the plasmid ( aac6’-lb-cr and catB4 ), these were misidentified as closely related genes: aac(6’)-lb-W104R, aac(6’)-lb-D181Y, aac(6’)-lb-AKT and catB3 .…”
Background
The timely and accurate diagnosis of bloodstream infection (BSI) is critical for patient management. With longstanding challenges for routine blood culture, metagenomics is a promising approach to rapidly provide sequence-based detection and characterisation of bloodborne bacteria. Long-read sequencing technologies have successfully supported the use of clinical metagenomics for syndromes such as respiratory illness, and modified approaches may address two requisite factors for metagenomics to be used as a BSI diagnostic: depletion of the high level of host DNA to then detect the low abundance of microbes in blood.
Methods
Blood samples from healthy donors were spiked with different concentrations of four prevalent causative species of BSI. All samples were then subjected to a modified saponin-based host DNA depletion protocol and optimised DNA extraction, whole genome amplification and debranching steps in preparation for sequencing, followed by bioinformatical analyses. Two related variants of the protocol are presented: 1mL of blood processed without bacterial enrichment, and 5mL of blood processed following a rapid bacterial enrichment protocol—SepsiPURE.
Results
After first identifying that a large proportion of host mitochondrial DNA remained, the host depletion process was optimised by increasing saponin concentration to 3% and scaling the reaction to allow more sample volume. Compared to non-depleted controls, the 3% saponin-based depletion protocol reduced the presence of host chromosomal and mitochondrial DNA < 106 and < 103 fold respectively. When the modified depletion method was further combined with a rapid bacterial enrichment method (SepsiPURE; with 5mL blood samples) the depletion of mitochondrial DNA improved by a further > 10X while also increasing detectable bacteria by > 10X. Parameters during DNA extraction, whole genome amplification and long-read sequencing were also adjusted, and subsequently amplicons were detected for each input bacterial species at each of the spiked concentrations, ranging from 50–100 colony forming units (CFU)/mL to 1–5 CFU/mL.
Conclusion
In this proof-of-concept study, four prevalent BSI causative species were detected in under 12 h to species level (with antimicrobial resistance determinants) at concentrations relevant to clinical blood samples. The use of a rapid and precise metagenomic protocols has the potential to advance the diagnosis of BSI.
“…Carbapenem-resistant Enterobacterales (CRE) are a major concern in the community and in healthcare settings [ 1 ]. Among the carbapenamases, NDM, with the exception of aztreonam, mediates resistance to all β-lactam antibiotics [ 2 ].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.